Skip to main content

Advertisement

SpringerLink
Log in

Pediatric Angioedema

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Angioedema is a self-limited nonpitting edema generally affecting the deeper layers of the skin and mucous membranes. It is the result of increased vascular permeability causing the leakage of fluid into the skin in response to potent vasodilators released by immunologic mediators. Two main pathways are thought to be implicated in angioedema. The mast cell pathway in which preformed mediators, such as histamine, rapidly formed mediators, leukotrienes and prostaglandins, are released from mast cells through IgE or direct activation. This is the most common pathway among children, with food, medications, and infections commonly implicated. The second pathway is the kinin pathway, most notably affected by angiotensin-converting enzyme (ACE) inhibitors and hereditary forms of angioedema, which ultimately results in the formation of bradykinin, a potent vasodilator. Angioedema is being encountered with increasing frequency, particularly among children and is important to recognize and treat for its life-threatening associated manifestations such as anaphylaxis and airway obstruction. Although angioedema is still not fully understood, we have broadened our understanding of the possible causes and clinical course of angioedema. An understanding of these potential causes and mechanisms by which angioedema can occur may guide the clinician in determining the need for diagnostic testing and the extent of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sackesen C, Sekerel BE, Orhan F, Kocabas CN, Tuncer A, Adalioglu G (2004) The etiology of different forms of urticaria in childhood. Pediatr Dermatol 21:102–108

    Article  PubMed  Google Scholar 

  2. Dibbern DA Jr, Dreskin SC (2004) Urticaria and angioedema: an overview. Immunol Allergy Clin North Am 24(v):141–162

    Article  PubMed  Google Scholar 

  3. Kaplan AP (2002) Clinical practice. Chronic urticaria and angioedema. N Engl J Med 346:175–179

    Article  PubMed  Google Scholar 

  4. Nzeako UC, Frigas E, Tremaine WJ (2001) Hereditary angioedema: a broad review for clinicians. Arch Intern Med 161:2417–2429

    Article  PubMed  CAS  Google Scholar 

  5. Allen KJ, Hill DJ, Heine RG (2006) 4. Food allergy in childhood. Med J Aust 185:394–400

    PubMed  Google Scholar 

  6. Settipane RA, Constantine HP, Settipane GA (1980) Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy 35:149–154

    Article  PubMed  CAS  Google Scholar 

  7. Capriles-Behrens E, Caplin J, Sanchez-Borges M (2000) NSAID facial angioedema in a selected pediatric atopic population. J Investig Allergol Clin Immunol 10:277–279

    PubMed  CAS  Google Scholar 

  8. Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F (2002) NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol 3:599–607

    Article  PubMed  Google Scholar 

  9. Bavbek S, Celik G, Pasaoglu G, Misirligil Z (2006) Rofecoxib, as a safe alternative for acetyl salicylic acid/nonsteroidal anti-inflammatory drug-intolerant patients. J Investig Allergol Clin Immunol 16:57–62

    PubMed  CAS  Google Scholar 

  10. Pacor ML, Di Lorenzo G, Biasi D, Barbagallo M, Corrocher R (2002) Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clin Exp Allergy 32:397–400

    Article  PubMed  CAS  Google Scholar 

  11. Zembowicz A, Mastalerz L, Setkowicz M, Radziszewski W, Szczeklik A (2003) Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol 139:1577–1582

    Article  PubMed  CAS  Google Scholar 

  12. Lenchner KI, Ditto AM (2004) Idiopathic anaphylaxis. Allergy Asthma Proc 25:S54–S56

    PubMed  Google Scholar 

  13. Kozel MM, Mekkes JR, Bossuyt PM, Bos JD (2001) Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 45:387–391

    Article  PubMed  CAS  Google Scholar 

  14. Kwong KY, Maalouf N, Jones CA (1998) Urticaria and angioedema: pathophysiology, diagnosis, and treatment. Pediatr Ann 27:719–724

    PubMed  CAS  Google Scholar 

  15. Sabroe RA, Black AK (1997) Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br J Dermatol 136:153–158

    Article  PubMed  CAS  Google Scholar 

  16. Agah R, Bandi V, Guntupalli KK (1997) Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med 23:793–796

    Article  PubMed  CAS  Google Scholar 

  17. Cugno M, Nussberger J, Cicardi M, Agostoni A (2003) Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 3:311–317

    Article  PubMed  CAS  Google Scholar 

  18. Brown NJ, Ray WA, Snowden M, Griffin MR (1996) Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 60:8–13

    Article  PubMed  CAS  Google Scholar 

  19. Abinun M (1999) Hereditary angio-oedema in children. Lancet 353:2242

    Article  PubMed  CAS  Google Scholar 

  20. Boyle RJ, Nikpour M, Tang ML (2005) Hereditary angio-oedema in children: a management guideline. Pediatr Allergy Immunol 16:288–294

    Article  PubMed  Google Scholar 

  21. Carugati A, Pappalardo E, Zingale LC, Cicardi M (2001) C1-inhibitor deficiency and angioedema. Mol Immunol 38:161–173

    Article  PubMed  CAS  Google Scholar 

  22. Bracho FA (2005) Hereditary angioedema. Curr Opin Hematol 12:493–498

    Article  PubMed  Google Scholar 

  23. Fay A, Abinun M (2002) Current management of hereditary angio-oedema (C′1 esterase inhibitor deficiency). J Clin Pathol 55:266–270

    PubMed  CAS  Google Scholar 

  24. Frank MM (2005) Hereditary angioedema. Curr Opin Pediatr 17:686–689

    Article  PubMed  Google Scholar 

  25. Kim JS, Pongracic JA (2004) Hereditary and acquired angioedema. Allergy Asthma Proc 25:S47–S49

    PubMed  Google Scholar 

  26. Frigas E, Nzeako UC (2002) Angioedema. Pathogenesis, differential diagnosis, and treatment. Clin Rev Allergy Immunol 23:217–231

    Article  PubMed  Google Scholar 

  27. Charlesworth EN (2002) Differential diagnosis of angioedema. Allergy Asthma Proc 23:337–339

    PubMed  Google Scholar 

  28. Zacharisen M (1999) Pediatric urticaria and angioedema. Immunol Allergy Clin North Am 19:363–382

    Article  Google Scholar 

  29. Shah UK, Jacobs IN (1999) Pediatric angioedema: ten years’ experience. Arch Otolaryngol Head Neck Surg 125:791–795

    PubMed  CAS  Google Scholar 

  30. Baxi S, Dinakar C (2005) Urticaria and angioedema. Immunol Allergy Clin North Am 25(vii):353–367

    Article  PubMed  Google Scholar 

  31. Green JJ, Heymann WR (2001) Urticaria and angioedema. Adv Dermatol 17:141–182

    PubMed  CAS  Google Scholar 

  32. Muller BA (2004) Urticaria and angioedema: a practical approach. Am Fam Physician 69:1123–1128

    PubMed  Google Scholar 

  33. Farkas H, Harmat G, Fust G, Varga L, Visy B (2002) Clinical management of hereditary angio-oedema in children. Pediatr Allergy Immunol 13:153–161

    Article  PubMed  Google Scholar 

  34. Adkinson N, Busse W, Holgate S (2003) Middleton’s allergy: principles and practice. Mosby, Philadelphia, PA

    Google Scholar 

  35. Ablin JN, Shoenfeld Y, Buskila D (2006) Fibromyalgia, infection and vaccination: two more parts in the etiological puzzle. J Autoimmun 27:145–152

    Article  PubMed  Google Scholar 

  36. Alper CA, Husain Z, Larsen CE, Dubey DP, Stein R, Day C, Baker A, Beyan H, Hawa M, Ola TO, Leslie RD (2006) Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes. J Autoimmun 27:89–95

    Article  PubMed  CAS  Google Scholar 

  37. Anaya JM, Castiblanco J, Tobon GJ, Garcia J, Abad V, Cuervo H, Velasquez A, Angel ID, Vega P, Arango A (2006) Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J Autoimmun 26:208–214

    Article  PubMed  CAS  Google Scholar 

  38. Awdeh ZL, Yunis EJ, Audeh MJ, Fici D, Pugliese A, Larsen CE, Alper CA (2006) A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease. J Autoimmun 27:174–181

    Article  PubMed  CAS  Google Scholar 

  39. Barral AM, Thomas HE, Ling EM, Darwiche R, Rodrigo E, Christen U, Ejrnaes M, Wolfe T, Kay TW, von Herrath MG (2006) SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes. J Autoimmun 27:166–173

    Article  PubMed  CAS  Google Scholar 

  40. Orban T, Kis J, Szereday L, Engelmann P, Farkas K, Jalahej H, Treszl A (2007) Reduced CD4+ T-cell-specific gene expression in human type 1 diabetes mellitus. J Autoimmun 28:177–187

    Article  PubMed  CAS  Google Scholar 

  41. Vandiedonck C, Giraud M, Garchon HJ (2005) Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex. J Autoimmun 25(Suppl):6–11

    Article  PubMed  CAS  Google Scholar 

  42. Yamamoto K, Yamada R (2005) Genome-wide single nucleotide polymorphism analyses of rheumatoid arthritis. J Autoimmun 25(Suppl):12–15

    Article  PubMed  CAS  Google Scholar 

  43. Strous RD, Shoenfeld Y (2006) Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun 27:71–80

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, 451 E. Health Sciences Drive, Suite 6510, Davis, CA, 95616, USA

    Anita Krishnamurthy, Stanley M. Naguwa & M. Eric Gershwin

Authors
  1. Anita Krishnamurthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stanley M. Naguwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Eric Gershwin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Eric Gershwin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krishnamurthy, A., Naguwa, S.M. & Gershwin, M.E. Pediatric Angioedema. Clinic Rev Allerg Immunol 34, 250–259 (2008). https://doi.org/10.1007/s12016-007-8037-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-007-8037-y

Keywords

Search

Navigation